Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Lidocaine and Prilocaine Cream USP. Lidocaine and Prilocaine ...

Cipla Ltd is quoting at Rs 1493.85, up 1.46% on the day as on 12:44 IST on the NSE. The stock is up 20.84% in last one year as compared to a 13.3% gain in NIFTY and a 40.24% gain in the Nifty Pharma.